Cyclandelate
- Level
- Commodity
- Parent
- 51411500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51411502This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4139O1OAY2. European Medicines Agency schedules Cyclandelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06841MIG. Cyclandelate generally arises in the molecular formula C17H24O3. The term CYCLANDELATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3 1962, list 4.) CYCLANDELATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyclandelate under HS 29181985 and SITC 51392. As of Q4 2014, CYCLANDELATE remains the US FDA Preferred Term for this commodity. Cyclandelate bears US NLM identifiers UMLS ID C0010525 and NCI Concept Code C77072. SMILES: CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O.
Same parent
Under 51411500 · 5Activities that produce or sell this
KBLI · 8Inherited from family 51410000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.